HERON THERAPEUTICS INC (HRTX)
US4277461020 - Common Stock
| TTM (2024-3-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -80.95M | -110.56M | -182.02M | -220.68M | -227.28M | |||
| Depreciation Amortization | 2.87M | 2.90M | 2.89M | 3.02M | 2.85M | |||
| Change In Working Capital | 7.23M | 16.79M | -10.51M | -35.08M | -13.01M | |||
| Interest Paid | 3.71M | 3.06M | 2.25M | 1.24M | 0.00 | |||
| Other non cash items | 27.45M | 32.08M | 42.73M | 49.39M | 52.62M | |||
| OPERATING CASH FLOW | -43.41M | -58.79M | -146.91M | -203.35M | -184.82M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -1.32M | -1.54M | -1.83M | -3.02M | -6.81M | |||
| Other Investing Activity | -16.24M | 19.54M | -1.50M | 35.75M | 215.77M | |||
| INVESTING CASH FLOW | -17.56M | 18.00M | -3.32M | 32.73M | 208.96M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | 24.35M | 0.00 | 148.96M | N/A | |||
| Stock Issued/Repurchased | 29.98M | 29.76M | 75.06M | 7.07M | 9.08M | |||
| Other Financing Activity | N/A | N/A | N/A | N/A | 30.00K | |||
| FINANCING CASH FLOW | 54.33M | 54.11M | 75.06M | 156.03M | 9.11M | |||
| CHANGE IN CASH | -6.63M | 13.31M | -75.17M | -14.59M | 33.25M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -43.41M | -58.79M | -146.91M | -203.35M | -184.82M | |||
| Capital Expenditure | -1.32M | -1.54M | -1.83M | -3.02M | -6.81M | |||
| FREE CASH FLOW | -44.73M | -60.33M | -148.74M | -206.37M | -191.63M | |||
All data in USD